The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Hydrochlorothiazide · HYDROCHLOROTHIAZIDE 12.5 mg/1 · Capsule, Gelatin Coated · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC 67544-0739-60 · 90 CAPSULE, GELATIN COATED in 1 PACKAGE · NDA AUTHORIZED GENERIC · View full market →
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Actavis Pharma, Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aphena Pharma Solutions - Tennessee, LLC | HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Proficient Rx LP | HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| QPharma, Inc. | HYDROCHLOROTHIAZIDE 12.5 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Hydrochlorothiazide — NDC 67544-0739-60," retrieved September 3, 2026, https://drugdashboards.com/drug/67544073960.
Free to cite with attribution — see how the data is put together.